CoChat

The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index; 16 of the 99 sources its claims cite were checked for support.

Indian Imaginaries of Chinese Success in the Global Herbal Medicine Market: A Critical Assessment

Kudlu, Chithprabha, Nichter, Mark · 2019 · Asian Medicine

Abstract

<section class="abstract">Abstract India’s share in the global herbal market is dwarfed by that of China. Public and policy discourse in India exhorts Ayurvedic stakeholders to emulate Chinese medicine’s “science-based approach” to expand their global market share. But contrary to popular perception in India, China has been largely unsuccessful in making inroads into the coveted Euro-American herbal medicine market. Chinese medicine’s global footprint is largely the result of historical-cultural links, diasporic influences, and acupuncture practitioners. With national traditional medicine policies increasingly shaped by the evidence-based regulatory paradigm, the future of these informal bottom-up pathways is uncertain. Ignoring the roots of Chinese medicine’s global career has led to a distorted image of its “success” as an outcome of state investment in scientific validation and standardization programs. Our findings underscore the need to critically examine the imaginaries of success that drive stakeholders of non-biomedical traditions toward scientization to earn legitimacy and profits in the global realm. </section>

Overview

CoChat Summary

TL;DR

The paper argues that Indian policy and public discourse wrongly attributes Chinese medicine’s global herbal-market success to a science-based, state-led model, while China has in fact largely failed to penetrate Euro-American evidence-based herbal markets. It attributes Chinese medicine’s global footprint mainly to historical-cultural links, diasporic networks, acupuncture, and diplomatic pathways, and warns that this distorted imaginary pushes Ayurveda toward scientization.

Key findings

  • India’s 2015–16 medicinal herb and herbal product exports were $358.6 million, about 0.5% of the global herbal market, while China’s exports were $3.8 billion, ten times India’s; however, in 2015 only 14.6% of Chinese herbal exports were finished products, with crude herbs and extracts over 80%.
  • Chinese medicine has barely breached Euro-American regulatory pathways: as of 2015, only 2 of 1,577 EU Traditional Use Registrations and 1 of 768 Well-Established Use authorizations were based on Chinese herbal medicines; only one Chinese herbal medicine-based product had received USFDA botanical pathway approval since 2004.
  • Most Chinese medicine sales are in Asian markets: East and Southeast Asia accounted for 60.7% of China’s raw and processed herbal medicine exports in 2015, and globalization also flowed through acupuncture, diaspora networks, and Cold War-era diplomatic/aid channels.
  • The EU’s Traditional Herbal Medicinal Products Directive disrupted bottom-up pathways: Chinese medicine product exports increased 6.4% in 2011 but plunged 22% in 2012, and one forecast predicted around 100,000 Chinese medicine workers would lose jobs post-THMPD.

Methods

  • Critical literature review over two years of over 1,000 English-language sources from PubMed, Science Direct, and Google Scholar, plus journals, press reports, industry reports, business case studies, and policy documents.
  • Supplemented by Kudlu’s field notes from seven national and international Ayurvedic conferences in India between 2008 and 2016 and by Nichter’s professional network; the authors lacked access to Chinese-language journals and relied on key review articles citing Chinese-language sources.
  • Analysis compares Indian claims of Chinese success with evidence on export composition, regulatory approvals, and bottom-up globalization pathways.

Limitations

  • Stated: the primary aim is to flag discrepancies and provide pointers for further investigation; the scope is limited to Chinese medicine pharmaceuticals; and the authors did not have access to Chinese-language journals, relying instead on English sources and reviews citing Chinese-language sources.
  • Evident: as a review, it does not present primary quantitative data or a systematic meta-analysis; the analysis of “Indian imaginaries” draws on selected scholarly, media, and policy sources plus conference field notes, so the representativeness of that discourse is not quantified.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1163/15734218-12341437

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

14 Valid · 14 Not valid · 64 Not checked · 70 Own results and interpretations

83 more claims · 2 with their cited sources checked

Create a free account to see all 162 claims and to verify the 3 references still open.

See all claims — free account
  • Probably not a substantial claim. 50
  • It may state two separate claims as one. 39

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 62 references

Research works printed but not linked: 15

  1. Agarwal, Paru, Shashi Alok, Amreen Fatima, and Amita Verma. 2013. 'Current Scenario of Herbal Technology Worldwide: An Overview.' International Journal of Pharmaceutical Sciences and Research 4(11): 4105-4117.
  2. Banerjee, Madhulika. 2004. 'Local Knowledge for World Market: Globalizing Ayurveda.' Economic and Political Weekly 39 (1): 89-93.
  3. Bode, Maarten. 2009. 'On the Effectiveness of Ayurvedic Medical Treatment: Humoral Pharmacology, Positivistic Science, and Soteriology.' Electronic Journal of Indian Medicine 2:1-24. Accessed November 10, 2017. https://ugp.rug.nl/eJIM/article/view/ 24718.
  4. Chi, Wenshu. 2015. 'Writing its Own Prescription.' Beijing Review . Accessed March 30, 2019. http://www.bjreview.com/Business/201511/t20151102\_800041718.html.
  5. China Economic Review. 2012. 'Africa Becomes Largest Export Market for Chinese Medicine.' November 5. Accessed March 30, 2019. http://www.chinaeconomic review.com/africa-becomes-largest-export-market-chinese-medicine.
  6. China Economic Review. 2013. 'Chinese Medicine Plays by Western Rules to Gain Acceptance.' July 5. Accessed March 30, 2019. http://www.chinaeconomicreview .com/traditional-Chinese-medicine-TCM-healthcare-pharmaceuticals-botanical -drugs-FDA.
  7. Clarke, Tainya C., Lindsey I. Black, Barbara J. Stussman, Patricia M. Barnes, and Richard L. Nahin. 2015. 'Trends in the Use of Complementary Health Approaches among Adults: United States, 2002-2012.' National Health Statistics Report 79:1-16. Accessed December 8, 2018. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573565/.
  8. Humes, Cynthia Ann. 2008. 'Maharishi Ayur-Veda: Perfect Health through Enlightened Marketing in America.' In Modern and Global Ayurveda: Pluralism and Paradigms , edited by D. Wujastyk and F. M. Smith, 309-32. Albany: State University of New York Press.
  9. Jasanoff, Sheila. 2015. 'Future Imperfect: Science, Technology, and the Imaginations of Modernity.' In Dreamscapes of Modernity: Sociotechnical Imaginaries and the Fabrication of Power , edited by S. Jasanoff and S. Kim, 1-33. Chicago: University of Chicago Press.
  10. Nichter, Mark, and Margaret Lock, eds. 2002. New Horizons in Medical Anthropology: Essays in Honor of Charles Leslie . London: Routledge.
  11. Pordié, Laurent, and Jean P. Gaudillière. 2014. 'The Reformulation Regime in Drug Discovery.' East Asian Science, Technology and Society 8 (1): 57-79.
  12. Press Information Bureau, Government of India, Ministry of Health and Family Welfare. 2014. 'Government to Push for Standardization in Ayurvedic Drug Production.' Accessed November 4, 2017. http://www.pib.nic.in/newsite/PrintRelease.aspx? relid=111136.
  13. Singh, R. H. 2015. 'Doing Ayush in India Today: Against all Odds.' Annals of Ayurvedic Medicine 4 (3-4): 62-63.
  14. Sujatha, V. 2011. 'What Could Integrative Medicine Mean?' Journal of Ayurveda and Integrative Medicine 2 (3): 115.
  15. Xiang, Lei, Jing Chen, Chun-Xiang Liu, Jia Lin, Jing Lou, and Hong-cai Shang. 2014. 'Status and Thoughts of Chinese Patent Medicines Seeking Approval in the US Market.' Chinese Journal of Integrative Medicine 20 (6): 403-8.

Cited by

See all 7

Metadata

Authors
Kudlu, C., & Nichter, M.
Affiliations
  • Independent Scholar
  • University of Arizona (US)
Venue
Asian Medicine
Published
2019-09-02
Volume
14
Issue
1
Pages
104-144
ISSN
  • 1573-420X (ISSN-L)
  • 1573-4218
OpenAlex
W2972843075
Cited by
7
References
62
Citations by year
2025: 3 · 2024: 1 · 2023: 2 · 2022: 1
FWCI
0.30
Type
journal article
Language
en
Open access
closed
Locations
Asian Medicine (publishedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Herbal Medicine and Trade Cooperation
  • Health Sciences › Medicine › Complementary and alternative medicine › Traditional Chinese Medicine Studies
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
Keywords
traditional Chinese medicine, herbal medicine market, Ayurveda, scientization, traditional medicine policy, evidence-based regulation, acupuncture, international expansion, India-China comparison

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Indian Imaginaries of Chinese Success in the Global Herbal Medicine Market: A Critical Assessment. https://app.cochat.ai/papers/10.1163/15734218-12341437
The paper
Kudlu, C., & Nichter, M. (2019). Indian Imaginaries of Chinese Success in the Global Herbal Medicine Market: A Critical Assessment. Asian Medicine. https://doi.org/10.1163/15734218-12341437

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.